QY Research > レポート一覧 > メディカルケア > 血清学的移植診断法世界市場の発展状況と動向 2024-2030

血清学的移植診断法世界市場の発展状況と動向 2024-2030

英文タイトル: Global Serological Transplant Diagnostics Market Insights, Forecast to 2030

血清学的移植診断法世界市場の発展状況と動向 2024-2030
  • レポートID:271466
  • 発表時期:2024-04-25
  • 訪問回数:864
  • ページ数:116
  • レポート形式:PDF
  • レポート言語:英語、日本語
  • グラフ数:141
  • レポートカテゴリ: メディカルケア

販売価格(消費税別)

販売価格(消費税別)

  •  
  • 個人版

    詳細
  • マルチユーザー版

    詳細
  • 企業版

    詳細

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=156.8円。
※米ドル表示価格+10%消費税。

英語版
日本語版
英語と日本語版

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=156.8円。
※米ドル表示価格+10%消費税。

shenQingYangBen

サンプルお申込み

shenQingYangBen

お問い合わせ

※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

biaoTi

概要

本報告書は血清学的移植診断法市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは血清学的移植診断法の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の血清学的移植診断法市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは血清学的移植診断法のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に血清学的移植診断法市場を分類しています。本研究に含まれる主な企業は:Bio-Rad Laboratories、Immucor、Siemens Healthineers、Ortho Clinical Diagnostics、Thermo Fisher Scientific、Agena Bioscience、AVIOQ、BAG Healthcare、BD、Beckman Coulter、Biogenuix、DIAGAST、Grifols、Hemo bioscience、Institut de Biotechnologies、Lorne Laboratories、MTC Invitro、Quotient Biodiagnostics、Tulip Group

地域別市場区分、地域別分析は以下の通り:
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント:
Kidney Transplantation
Liver Transplantation
Heart Transplantation
Lung Transplantation
Pancreas Transplantation

用途別の市場セグメント:
Hospitals, Blood Banks and Transplant Centers
Donor Registries and Research Laboratories

レポートの詳細内容
世界の血清学的移植診断法市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、血清学的移植診断法タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の血清学的移植診断法収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の血清学的移植診断法市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、血清学的移植診断法市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

血清学的移植診断法のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
1章:血清学的移植診断法のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント(製品タイプ、用途など)のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。(20192030
2章:血清学的移植診断法の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。(20192030
3血清学的移植診断法企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。(20192030
4章:各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(20192024
5章:血清学的移植診断法の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。(20192030
6章:北米(米国、カナダ)のタイプ別、アプリケーション別、国別、各セグメントの収益。(20192030
7章:ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。(20192030
8章:中国の種類別、および用途別、各セグメントの収益。(20192030
9章アジア(中国を除く)の種類別、用途別、地域別、セグメントごとの収益。(20192030
10章:中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。(20192030
11章:血清学的移植診断法の主要企業の概要を提供し、製品の説明と仕様、血清学的移植診断法の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。(20192024
12章:アナリストの見解/結論

biaoTi

概要

Serological transplant diagnostics are used for all types of transplants. The products are developed based on the agglutination and complement fixation technology.
Market Analysis and Insights: Global Serological Transplant Diagnostics Market
The global Serological Transplant Diagnostics market is projected to grow from US$ 354.4 million in 2024 to US$ 405.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.3% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Serological Transplant Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Serological Transplant Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Serological Transplant Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Serological Transplant Diagnostics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Serological Transplant Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Serological Transplant Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Bio-Rad Laboratories, Immucor, Siemens Healthineers, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Agena Bioscience, AVIOQ, BAG Healthcare and BD, etc.

Market Segmentation
By Company
    Bio-Rad Laboratories
    Immucor
    Siemens Healthineers
    Ortho Clinical Diagnostics
    Thermo Fisher Scientific
    Agena Bioscience
    AVIOQ
    BAG Healthcare
    BD
    Beckman Coulter
    Biogenuix
    DIAGAST
    Grifols
    Hemo bioscience
    Institut de Biotechnologies
    Lorne Laboratories
    MTC Invitro
    Quotient Biodiagnostics
    Tulip Group

Segment by Type
    Kidney Transplantation
    Liver Transplantation
    Heart Transplantation
    Lung Transplantation
    Pancreas Transplantation

Segment by Application
    Hospitals, Blood Banks and Transplant Centers
    Donor Registries and Research Laboratories

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Serological Transplant Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Serological Transplant Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Serological Transplant Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
biaoTi

総目録

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Serological Transplant Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Kidney Transplantation
1.2.3 Liver Transplantation
1.2.4 Heart Transplantation
1.2.5 Lung Transplantation
1.2.6 Pancreas Transplantation
1.3 Market by Application
1.3.1 Global Serological Transplant Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals, Blood Banks and Transplant Centers
1.3.3 Donor Registries and Research Laboratories
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Serological Transplant Diagnostics Market Perspective (2019-2030)
2.2 Global Serological Transplant Diagnostics Growth Trends by Region
2.2.1 Serological Transplant Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Serological Transplant Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Serological Transplant Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Serological Transplant Diagnostics Market Dynamics
2.3.1 Serological Transplant Diagnostics Industry Trends
2.3.2 Serological Transplant Diagnostics Market Drivers
2.3.3 Serological Transplant Diagnostics Market Challenges
2.3.4 Serological Transplant Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Revenue Serological Transplant Diagnostics by Players
3.1.1 Global Serological Transplant Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Serological Transplant Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Serological Transplant Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Serological Transplant Diagnostics, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Serological Transplant Diagnostics Market Concentration Ratio
3.4.1 Global Serological Transplant Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Serological Transplant Diagnostics Revenue in 2023
3.5 Global Key Players of Serological Transplant Diagnostics Head office and Area Served
3.6 Global Key Players of Serological Transplant Diagnostics, Product and Application
3.7 Global Key Players of Serological Transplant Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans

4 Serological Transplant Diagnostics Breakdown Data by Type
4.1 Global Serological Transplant Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Serological Transplant Diagnostics Forecasted Market Size by Type (2025-2030)

5 Serological Transplant Diagnostics Breakdown Data by Application
5.1 Global Serological Transplant Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Serological Transplant Diagnostics Forecasted Market Size by Application (2025-2030)

6 North America
6.1 North America Serological Transplant Diagnostics Market Size (2019-2030)
6.2 North America Serological Transplant Diagnostics Market Size by Type
6.2.1 North America Serological Transplant Diagnostics Market Size by Type (2019-2024)
6.2.2 North America Serological Transplant Diagnostics Market Size by Type (2025-2030)
6.2.3 North America Serological Transplant Diagnostics Market Share by Type (2019-2030)
6.3 North America Serological Transplant Diagnostics Market Size by Application
6.3.1 North America Serological Transplant Diagnostics Market Size by Application (2019-2024)
6.3.2 North America Serological Transplant Diagnostics Market Size by Application (2025-2030)
6.3.3 North America Serological Transplant Diagnostics Market Share by Application (2019-2030)
6.4 North America Serological Transplant Diagnostics Market Size by Country
6.4.1 North America Serological Transplant Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Serological Transplant Diagnostics Market Size by Country (2019-2024)
6.4.3 North America Serological Transplant Diagnostics Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada

7 Europe
7.1 Europe Serological Transplant Diagnostics Market Size (2019-2030)
7.2 Europe Serological Transplant Diagnostics Market Size by Type
7.2.1 Europe Serological Transplant Diagnostics Market Size by Type (2019-2024)
7.2.2 Europe Serological Transplant Diagnostics Market Size by Type (2025-2030)
7.2.3 Europe Serological Transplant Diagnostics Market Share by Type (2019-2030)
7.3 Europe Serological Transplant Diagnostics Market Size by Application
7.3.1 Europe Serological Transplant Diagnostics Market Size by Application (2019-2024)
7.3.2 Europe Serological Transplant Diagnostics Market Size by Application (2025-2030)
7.3.3 Europe Serological Transplant Diagnostics Market Share by Application (2019-2030)
7.4 Europe Serological Transplant Diagnostics Market Size by Country
7.4.1 Europe Serological Transplant Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Serological Transplant Diagnostics Market Size by Country (2019-2024)
7.4.3 Europe Serological Transplant Diagnostics Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries

8 China
8.1 China Serological Transplant Diagnostics Market Size (2019-2030)
8.2 China Serological Transplant Diagnostics Market Size by Type
8.2.1 China Serological Transplant Diagnostics Market Size by Type (2019-2024)
8.2.2 China Serological Transplant Diagnostics Market Size by Type (2025-2030)
8.2.3 China Serological Transplant Diagnostics Market Share by Type (2019-2030)
8.3 China Serological Transplant Diagnostics Market Size by Application
8.3.1 China Serological Transplant Diagnostics Market Size by Application (2019-2024)
8.3.2 China Serological Transplant Diagnostics Market Size by Application (2025-2030)
8.3.3 China Serological Transplant Diagnostics Market Share by Application (2019-2030)

9 Asia (excluding China)
9.1 Asia Serological Transplant Diagnostics Market Size (2019-2030)
9.2 Asia Serological Transplant Diagnostics Market Size by Type
9.2.1 Asia Serological Transplant Diagnostics Market Size by Type (2019-2024)
9.2.2 Asia Serological Transplant Diagnostics Market Size by Type (2025-2030)
9.2.3 Asia Serological Transplant Diagnostics Market Share by Type (2019-2030)
9.3 Asia Serological Transplant Diagnostics Market Size by Application
9.3.1 Asia Serological Transplant Diagnostics Market Size by Application (2019-2024)
9.3.2 Asia Serological Transplant Diagnostics Market Size by Application (2025-2030)
9.3.3 Asia Serological Transplant Diagnostics Market Share by Application (2019-2030)
9.4 Asia Serological Transplant Diagnostics Market Size by Region
9.4.1 Asia Serological Transplant Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Serological Transplant Diagnostics Market Size by Region (2019-2024)
9.4.3 Asia Serological Transplant Diagnostics Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia

10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Serological Transplant Diagnostics Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Serological Transplant Diagnostics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Serological Transplant Diagnostics Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Serological Transplant Diagnostics Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Serological Transplant Diagnostics Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Serological Transplant Diagnostics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Serological Transplant Diagnostics Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Serological Transplant Diagnostics Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Serological Transplant Diagnostics Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Serological Transplant Diagnostics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Serological Transplant Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Serological Transplant Diagnostics Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Serological Transplant Diagnostics Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries

11 Key Players Profiles
11.1 Bio-Rad Laboratories
11.1.1 Bio-Rad Laboratories Company Details
11.1.2 Bio-Rad Laboratories Business Overview
11.1.3 Bio-Rad Laboratories Serological Transplant Diagnostics Introduction
11.1.4 Bio-Rad Laboratories Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.1.5 Bio-Rad Laboratories Recent Developments
11.2 Immucor
11.2.1 Immucor Company Details
11.2.2 Immucor Business Overview
11.2.3 Immucor Serological Transplant Diagnostics Introduction
11.2.4 Immucor Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.2.5 Immucor Recent Developments
11.3 Siemens Healthineers
11.3.1 Siemens Healthineers Company Details
11.3.2 Siemens Healthineers Business Overview
11.3.3 Siemens Healthineers Serological Transplant Diagnostics Introduction
11.3.4 Siemens Healthineers Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.3.5 Siemens Healthineers Recent Developments
11.4 Ortho Clinical Diagnostics
11.4.1 Ortho Clinical Diagnostics Company Details
11.4.2 Ortho Clinical Diagnostics Business Overview
11.4.3 Ortho Clinical Diagnostics Serological Transplant Diagnostics Introduction
11.4.4 Ortho Clinical Diagnostics Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.4.5 Ortho Clinical Diagnostics Recent Developments
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Serological Transplant Diagnostics Introduction
11.5.4 Thermo Fisher Scientific Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.5.5 Thermo Fisher Scientific Recent Developments
11.6 Agena Bioscience
11.6.1 Agena Bioscience Company Details
11.6.2 Agena Bioscience Business Overview
11.6.3 Agena Bioscience Serological Transplant Diagnostics Introduction
11.6.4 Agena Bioscience Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.6.5 Agena Bioscience Recent Developments
11.7 AVIOQ
11.7.1 AVIOQ Company Details
11.7.2 AVIOQ Business Overview
11.7.3 AVIOQ Serological Transplant Diagnostics Introduction
11.7.4 AVIOQ Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.7.5 AVIOQ Recent Developments
11.8 BAG Healthcare
11.8.1 BAG Healthcare Company Details
11.8.2 BAG Healthcare Business Overview
11.8.3 BAG Healthcare Serological Transplant Diagnostics Introduction
11.8.4 BAG Healthcare Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.8.5 BAG Healthcare Recent Developments
11.9 BD
11.9.1 BD Company Details
11.9.2 BD Business Overview
11.9.3 BD Serological Transplant Diagnostics Introduction
11.9.4 BD Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.9.5 BD Recent Developments
11.10 Beckman Coulter
11.10.1 Beckman Coulter Company Details
11.10.2 Beckman Coulter Business Overview
11.10.3 Beckman Coulter Serological Transplant Diagnostics Introduction
11.10.4 Beckman Coulter Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.10.5 Beckman Coulter Recent Developments
11.11 Biogenuix
11.11.1 Biogenuix Company Details
11.11.2 Biogenuix Business Overview
11.11.3 Biogenuix Serological Transplant Diagnostics Introduction
11.11.4 Biogenuix Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.11.5 Biogenuix Recent Developments
11.12 DIAGAST
11.12.1 DIAGAST Company Details
11.12.2 DIAGAST Business Overview
11.12.3 DIAGAST Serological Transplant Diagnostics Introduction
11.12.4 DIAGAST Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.12.5 DIAGAST Recent Developments
11.13 Grifols
11.13.1 Grifols Company Details
11.13.2 Grifols Business Overview
11.13.3 Grifols Serological Transplant Diagnostics Introduction
11.13.4 Grifols Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.13.5 Grifols Recent Developments
11.14 Hemo bioscience
11.14.1 Hemo bioscience Company Details
11.14.2 Hemo bioscience Business Overview
11.14.3 Hemo bioscience Serological Transplant Diagnostics Introduction
11.14.4 Hemo bioscience Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.14.5 Hemo bioscience Recent Developments
11.15 Institut de Biotechnologies
11.15.1 Institut de Biotechnologies Company Details
11.15.2 Institut de Biotechnologies Business Overview
11.15.3 Institut de Biotechnologies Serological Transplant Diagnostics Introduction
11.15.4 Institut de Biotechnologies Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.15.5 Institut de Biotechnologies Recent Developments
11.16 Lorne Laboratories
11.16.1 Lorne Laboratories Company Details
11.16.2 Lorne Laboratories Business Overview
11.16.3 Lorne Laboratories Serological Transplant Diagnostics Introduction
11.16.4 Lorne Laboratories Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.16.5 Lorne Laboratories Recent Developments
11.17 MTC Invitro
11.17.1 MTC Invitro Company Details
11.17.2 MTC Invitro Business Overview
11.17.3 MTC Invitro Serological Transplant Diagnostics Introduction
11.17.4 MTC Invitro Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.17.5 MTC Invitro Recent Developments
11.18 Quotient Biodiagnostics
11.18.1 Quotient Biodiagnostics Company Details
11.18.2 Quotient Biodiagnostics Business Overview
11.18.3 Quotient Biodiagnostics Serological Transplant Diagnostics Introduction
11.18.4 Quotient Biodiagnostics Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.18.5 Quotient Biodiagnostics Recent Developments
11.19 Tulip Group
11.19.1 Tulip Group Company Details
11.19.2 Tulip Group Business Overview
11.19.3 Tulip Group Serological Transplant Diagnostics Introduction
11.19.4 Tulip Group Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.19.5 Tulip Group Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

biaoTi

表と図のリスト

List of Tables
    Table 1. Global Serological Transplant Diagnostics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Kidney Transplantation
    Table 3. Key Players of Liver Transplantation
    Table 4. Key Players of Heart Transplantation
    Table 5. Key Players of Lung Transplantation
    Table 6. Key Players of Pancreas Transplantation
    Table 7. Global Serological Transplant Diagnostics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 8. Global Serological Transplant Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Serological Transplant Diagnostics Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Serological Transplant Diagnostics Market Share by Region (2019-2024)
    Table 11. Global Serological Transplant Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Serological Transplant Diagnostics Market Share by Region (2025-2030)
    Table 13. Serological Transplant Diagnostics Market Trends
    Table 14. Serological Transplant Diagnostics Market Drivers
    Table 15. Serological Transplant Diagnostics Market Challenges
    Table 16. Serological Transplant Diagnostics Market Restraints
    Table 17. Global Serological Transplant Diagnostics Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Serological Transplant Diagnostics Revenue Share by Players (2019-2024)
    Table 19. Global Top Serological Transplant Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Serological Transplant Diagnostics as of 2023)
    Table 20. Global Serological Transplant Diagnostics Industry Ranking 2022 VS 2023 VS 2024
    Table 21. Global 5 Largest Players Market Share by Serological Transplant Diagnostics Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Global Key Players of Serological Transplant Diagnostics, Headquarters and Area Served
    Table 23. Global Key Players of Serological Transplant Diagnostics, Product and Application
    Table 24. Global Key Players of Serological Transplant Diagnostics, Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Serological Transplant Diagnostics Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Serological Transplant Diagnostics Revenue Market Share by Type (2019-2024)
    Table 28. Global Serological Transplant Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Serological Transplant Diagnostics Revenue Market Share by Type (2025-2030)
    Table 30. Global Serological Transplant Diagnostics Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Serological Transplant Diagnostics Revenue Share by Application (2019-2024)
    Table 32. Global Serological Transplant Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Serological Transplant Diagnostics Revenue Share by Application (2025-2030)
    Table 34. North America Serological Transplant Diagnostics Market Size by Type (2019-2024) & (US$ Million)
    Table 35. North America Serological Transplant Diagnostics Market Size by Type (2025-2030) & (US$ Million)
    Table 36. North America Serological Transplant Diagnostics Market Size by Application (2019-2024) & (US$ Million)
    Table 37. North America Serological Transplant Diagnostics Market Size by Application (2025-2030) & (US$ Million)
    Table 38. North America Serological Transplant Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. North America Serological Transplant Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 40. North America Serological Transplant Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Europe Serological Transplant Diagnostics Market Size by Type (2019-2024) & (US$ Million)
    Table 42. Europe Serological Transplant Diagnostics Market Size by Type (2025-2030) & (US$ Million)
    Table 43. Europe Serological Transplant Diagnostics Market Size by Application (2019-2024) & (US$ Million)
    Table 44. Europe Serological Transplant Diagnostics Market Size by Application (2025-2030) & (US$ Million)
    Table 45. Europe Serological Transplant Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Europe Serological Transplant Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Europe Serological Transplant Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 48. China Serological Transplant Diagnostics Market Size by Type (2019-2024) & (US$ Million)
    Table 49. China Serological Transplant Diagnostics Market Size by Type (2025-2030) & (US$ Million)
    Table 50. China Serological Transplant Diagnostics Market Size by Application (2019-2024) & (US$ Million)
    Table 51. China Serological Transplant Diagnostics Market Size by Application (2025-2030) & (US$ Million)
    Table 52. Asia Serological Transplant Diagnostics Market Size by Type (2019-2024) & (US$ Million)
    Table 53. Asia Serological Transplant Diagnostics Market Size by Type (2025-2030) & (US$ Million)
    Table 54. Asia Serological Transplant Diagnostics Market Size by Application (2019-2024) & (US$ Million)
    Table 55. Asia Serological Transplant Diagnostics Market Size by Application (2025-2030) & (US$ Million)
    Table 56. Asia Serological Transplant Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 57. Asia Serological Transplant Diagnostics Market Size by Region (2019-2024) & (US$ Million)
    Table 58. Asia Serological Transplant Diagnostics Market Size by Region (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Serological Transplant Diagnostics Market Size by Type (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Serological Transplant Diagnostics Market Size by Type (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Serological Transplant Diagnostics Market Size by Application (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Serological Transplant Diagnostics Market Size by Application (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Serological Transplant Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 64. Middle East, Africa, and Latin America Serological Transplant Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Serological Transplant Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 66. Bio-Rad Laboratories Company Details
    Table 67. Bio-Rad Laboratories Business Overview
    Table 68. Bio-Rad Laboratories Serological Transplant Diagnostics Product
    Table 69. Bio-Rad Laboratories Revenue in Serological Transplant Diagnostics Business (2019-2024) & (US$ Million)
    Table 70. Bio-Rad Laboratories Recent Developments
    Table 71. Immucor Company Details
    Table 72. Immucor Business Overview
    Table 73. Immucor Serological Transplant Diagnostics Product
    Table 74. Immucor Revenue in Serological Transplant Diagnostics Business (2019-2024) & (US$ Million)
    Table 75. Immucor Recent Developments
    Table 76. Siemens Healthineers Company Details
    Table 77. Siemens Healthineers Business Overview
    Table 78. Siemens Healthineers Serological Transplant Diagnostics Product
    Table 79. Siemens Healthineers Revenue in Serological Transplant Diagnostics Business (2019-2024) & (US$ Million)
    Table 80. Siemens Healthineers Recent Developments
    Table 81. Ortho Clinical Diagnostics Company Details
    Table 82. Ortho Clinical Diagnostics Business Overview
    Table 83. Ortho Clinical Diagnostics Serological Transplant Diagnostics Product
    Table 84. Ortho Clinical Diagnostics Revenue in Serological Transplant Diagnostics Business (2019-2024) & (US$ Million)
    Table 85. Ortho Clinical Diagnostics Recent Developments
    Table 86. Thermo Fisher Scientific Company Details
    Table 87. Thermo Fisher Scientific Business Overview
    Table 88. Thermo Fisher Scientific Serological Transplant Diagnostics Product
    Table 89. Thermo Fisher Scientific Revenue in Serological Transplant Diagnostics Business (2019-2024) & (US$ Million)
    Table 90. Thermo Fisher Scientific Recent Developments
    Table 91. Agena Bioscience Company Details
    Table 92. Agena Bioscience Business Overview
    Table 93. Agena Bioscience Serological Transplant Diagnostics Product
    Table 94. Agena Bioscience Revenue in Serological Transplant Diagnostics Business (2019-2024) & (US$ Million)
    Table 95. Agena Bioscience Recent Developments
    Table 96. AVIOQ Company Details
    Table 97. AVIOQ Business Overview
    Table 98. AVIOQ Serological Transplant Diagnostics Product
    Table 99. AVIOQ Revenue in Serological Transplant Diagnostics Business (2019-2024) & (US$ Million)
    Table 100. AVIOQ Recent Developments
    Table 101. BAG Healthcare Company Details
    Table 102. BAG Healthcare Business Overview
    Table 103. BAG Healthcare Serological Transplant Diagnostics Product
    Table 104. BAG Healthcare Revenue in Serological Transplant Diagnostics Business (2019-2024) & (US$ Million)
    Table 105. BAG Healthcare Recent Developments
    Table 106. BD Company Details
    Table 107. BD Business Overview
    Table 108. BD Serological Transplant Diagnostics Product
    Table 109. BD Revenue in Serological Transplant Diagnostics Business (2019-2024) & (US$ Million)
    Table 110. BD Recent Developments
    Table 111. Beckman Coulter Company Details
    Table 112. Beckman Coulter Business Overview
    Table 113. Beckman Coulter Serological Transplant Diagnostics Product
    Table 114. Beckman Coulter Revenue in Serological Transplant Diagnostics Business (2019-2024) & (US$ Million)
    Table 115. Beckman Coulter Recent Developments
    Table 116. Biogenuix Company Details
    Table 117. Biogenuix Business Overview
    Table 118. Biogenuix Serological Transplant Diagnostics Product
    Table 119. Biogenuix Revenue in Serological Transplant Diagnostics Business (2019-2024) & (US$ Million)
    Table 120. Biogenuix Recent Developments
    Table 121. DIAGAST Company Details
    Table 122. DIAGAST Business Overview
    Table 123. DIAGAST Serological Transplant Diagnostics Product
    Table 124. DIAGAST Revenue in Serological Transplant Diagnostics Business (2019-2024) & (US$ Million)
    Table 125. DIAGAST Recent Developments
    Table 126. Grifols Company Details
    Table 127. Grifols Business Overview
    Table 128. Grifols Serological Transplant Diagnostics Product
    Table 129. Grifols Revenue in Serological Transplant Diagnostics Business (2019-2024) & (US$ Million)
    Table 130. Grifols Recent Developments
    Table 131. Hemo bioscience Company Details
    Table 132. Hemo bioscience Business Overview
    Table 133. Hemo bioscience Serological Transplant Diagnostics Product
    Table 134. Hemo bioscience Revenue in Serological Transplant Diagnostics Business (2019-2024) & (US$ Million)
    Table 135. Hemo bioscience Recent Developments
    Table 136. Institut de Biotechnologies Company Details
    Table 137. Institut de Biotechnologies Business Overview
    Table 138. Institut de Biotechnologies Serological Transplant Diagnostics Product
    Table 139. Institut de Biotechnologies Revenue in Serological Transplant Diagnostics Business (2019-2024) & (US$ Million)
    Table 140. Institut de Biotechnologies Recent Developments
    Table 141. Lorne Laboratories Company Details
    Table 142. Lorne Laboratories Business Overview
    Table 143. Lorne Laboratories Serological Transplant Diagnostics Product
    Table 144. Lorne Laboratories Revenue in Serological Transplant Diagnostics Business (2019-2024) & (US$ Million)
    Table 145. Lorne Laboratories Recent Developments
    Table 146. MTC Invitro Company Details
    Table 147. MTC Invitro Business Overview
    Table 148. MTC Invitro Serological Transplant Diagnostics Product
    Table 149. MTC Invitro Revenue in Serological Transplant Diagnostics Business (2019-2024) & (US$ Million)
    Table 150. MTC Invitro Recent Developments
    Table 151. Quotient Biodiagnostics Company Details
    Table 152. Quotient Biodiagnostics Business Overview
    Table 153. Quotient Biodiagnostics Serological Transplant Diagnostics Product
    Table 154. Quotient Biodiagnostics Revenue in Serological Transplant Diagnostics Business (2019-2024) & (US$ Million)
    Table 155. Quotient Biodiagnostics Recent Developments
    Table 156. Tulip Group Company Details
    Table 157. Tulip Group Business Overview
    Table 158. Tulip Group Serological Transplant Diagnostics Product
    Table 159. Tulip Group Revenue in Serological Transplant Diagnostics Business (2019-2024) & (US$ Million)
    Table 160. Tulip Group Recent Developments
    Table 161. Research Programs/Design for This Report
    Table 162. Key Data Information from Secondary Sources
    Table 163. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Serological Transplant Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Serological Transplant Diagnostics Market Share by Type: 2023 VS 2030
    Figure 3. Kidney Transplantation Features
    Figure 4. Liver Transplantation Features
    Figure 5. Heart Transplantation Features
    Figure 6. Lung Transplantation Features
    Figure 7. Pancreas Transplantation Features
    Figure 8. Global Serological Transplant Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Serological Transplant Diagnostics Market Share by Application: 2023 VS 2030
    Figure 10. Hospitals, Blood Banks and Transplant Centers Case Studies
    Figure 11. Donor Registries and Research Laboratories Case Studies
    Figure 12. Serological Transplant Diagnostics Report Years Considered
    Figure 13. Global Serological Transplant Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Serological Transplant Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Serological Transplant Diagnostics Market Share by Region: 2023 VS 2030
    Figure 16. Global Serological Transplant Diagnostics Market Share by Players in 2023
    Figure 17. Global Top Serological Transplant Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Serological Transplant Diagnostics as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Serological Transplant Diagnostics Revenue in 2023
    Figure 19. North America Serological Transplant Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Serological Transplant Diagnostics Market Share by Type (2019-2030)
    Figure 21. North America Serological Transplant Diagnostics Market Share by Application (2019-2030)
    Figure 22. North America Serological Transplant Diagnostics Market Share by Country (2019-2030)
    Figure 23. United States Serological Transplant Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Serological Transplant Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Serological Transplant Diagnostics Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Serological Transplant Diagnostics Market Share by Type (2019-2030)
    Figure 27. Europe Serological Transplant Diagnostics Market Share by Application (2019-2030)
    Figure 28. Europe Serological Transplant Diagnostics Market Share by Country (2019-2030)
    Figure 29. Germany Serological Transplant Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Serological Transplant Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Serological Transplant Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Serological Transplant Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Serological Transplant Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Serological Transplant Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Serological Transplant Diagnostics Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Serological Transplant Diagnostics Market Share by Type (2019-2030)
    Figure 37. China Serological Transplant Diagnostics Market Share by Application (2019-2030)
    Figure 38. Asia Serological Transplant Diagnostics Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Serological Transplant Diagnostics Market Share by Type (2019-2030)
    Figure 40. Asia Serological Transplant Diagnostics Market Share by Application (2019-2030)
    Figure 41. Asia Serological Transplant Diagnostics Market Share by Region (2019-2030)
    Figure 42. Japan Serological Transplant Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Serological Transplant Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Serological Transplant Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Serological Transplant Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Serological Transplant Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Serological Transplant Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Serological Transplant Diagnostics Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Serological Transplant Diagnostics Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Serological Transplant Diagnostics Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Serological Transplant Diagnostics Market Share by Country (2019-2030)
    Figure 52. Brazil Serological Transplant Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Serological Transplant Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Serological Transplant Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Serological Transplant Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Serological Transplant Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Serological Transplant Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Bio-Rad Laboratories Revenue Growth Rate in Serological Transplant Diagnostics Business (2019-2024)
    Figure 59. Immucor Revenue Growth Rate in Serological Transplant Diagnostics Business (2019-2024)
    Figure 60. Siemens Healthineers Revenue Growth Rate in Serological Transplant Diagnostics Business (2019-2024)
    Figure 61. Ortho Clinical Diagnostics Revenue Growth Rate in Serological Transplant Diagnostics Business (2019-2024)
    Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Serological Transplant Diagnostics Business (2019-2024)
    Figure 63. Agena Bioscience Revenue Growth Rate in Serological Transplant Diagnostics Business (2019-2024)
    Figure 64. AVIOQ Revenue Growth Rate in Serological Transplant Diagnostics Business (2019-2024)
    Figure 65. BAG Healthcare Revenue Growth Rate in Serological Transplant Diagnostics Business (2019-2024)
    Figure 66. BD Revenue Growth Rate in Serological Transplant Diagnostics Business (2019-2024)
    Figure 67. Beckman Coulter Revenue Growth Rate in Serological Transplant Diagnostics Business (2019-2024)
    Figure 68. Biogenuix Revenue Growth Rate in Serological Transplant Diagnostics Business (2019-2024)
    Figure 69. DIAGAST Revenue Growth Rate in Serological Transplant Diagnostics Business (2019-2024)
    Figure 70. Grifols Revenue Growth Rate in Serological Transplant Diagnostics Business (2019-2024)
    Figure 71. Hemo bioscience Revenue Growth Rate in Serological Transplant Diagnostics Business (2019-2024)
    Figure 72. Institut de Biotechnologies Revenue Growth Rate in Serological Transplant Diagnostics Business (2019-2024)
    Figure 73. Lorne Laboratories Revenue Growth Rate in Serological Transplant Diagnostics Business (2019-2024)
    Figure 74. MTC Invitro Revenue Growth Rate in Serological Transplant Diagnostics Business (2019-2024)
    Figure 75. Quotient Biodiagnostics Revenue Growth Rate in Serological Transplant Diagnostics Business (2019-2024)
    Figure 76. Tulip Group Revenue Growth Rate in Serological Transplant Diagnostics Business (2019-2024)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
当社から購入のメリット
サンプル提供

01. サンプル提供

ご購入前にサンプル(英語、日本語)が提供可能。

カスタマイズサービス

02. カスタマイズサービス

レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。

プロフェッショナルな日本語翻訳

03. プロフェッショナルな日本語翻訳

AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。

多言語コミュニケーション

04. 多言語コミュニケーション

日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。

 お支払方法

05. お支払方法

銀行振込(納品後、ご請求書送付)。

アフターサービス

06. アフターサービス

ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。

ご注文方法

請求書払いの場合:

  • yuan01

    レポート選択

  • yuan01

    見積もり依頼

  • yuan01

    メールでのご注文

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)

  • yuan01

    決済(後払い)

クレジットカード決済の場合:

  • yuan01

    レポート選択

  • yuan01

    ウェブサイトでのご注文

  • yuan01

    決済

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)